[{"@context":"http:\/\/schema.org\/","@type":"BlogPosting","@id":"https:\/\/wiki.edu.vn\/en\/wiki19\/atazanavir-cobicistat-wikipedia\/#BlogPosting","mainEntityOfPage":"https:\/\/wiki.edu.vn\/en\/wiki19\/atazanavir-cobicistat-wikipedia\/","headline":"Atazanavir\/cobicistat – Wikipedia","name":"Atazanavir\/cobicistat – Wikipedia","description":"From Wikipedia, the free encyclopedia Combination drug for HIV Atazanavir\/cobicistat, sold under the brand name Evotaz, is a fixed-dose combination","datePublished":"2019-07-02","dateModified":"2019-07-02","author":{"@type":"Person","@id":"https:\/\/wiki.edu.vn\/en\/wiki19\/author\/lordneo\/#Person","name":"lordneo","url":"https:\/\/wiki.edu.vn\/en\/wiki19\/author\/lordneo\/","image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/c9645c498c9701c88b89b8537773dd7c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c9645c498c9701c88b89b8537773dd7c?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Enzyklop\u00e4die","logo":{"@type":"ImageObject","@id":"https:\/\/wiki.edu.vn\/wiki4\/wp-content\/uploads\/2023\/08\/download.jpg","url":"https:\/\/wiki.edu.vn\/wiki4\/wp-content\/uploads\/2023\/08\/download.jpg","width":600,"height":60}},"image":{"@type":"ImageObject","@id":"https:\/\/www.wikimedia.org\/static\/images\/wmf-logo.png","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-logo.png","height":"101","width":"135"},"url":"https:\/\/wiki.edu.vn\/en\/wiki19\/atazanavir-cobicistat-wikipedia\/","about":["Wiki"],"wordCount":2809,"articleBody":"From Wikipedia, the free encyclopediaCombination drug for HIVAtazanavir\/cobicistat, sold under the brand name Evotaz, is a fixed-dose combination antiretroviral medication used to treat and prevent HIV\/AIDS.[2][3] It contains atazanavir and cobicistat.[2][3][4] Atazanavir is an HIV protease inhibitor and cobicistat is an inhibitor of cytochrome P450 (CYP) enzymes of the CYP3A family.[2]Atazanavir\/cobicistat was approved by the Food and Drug Administration (FDA) for medical use in United States in January 2015.[5][6] It was approved for medical use in the European Union in July 2015.[3]Medical uses[edit]Atazanavir\/cobicistat is indicated for use in combination with other antiretroviral agents for the treatment of HIV\u20111 infection in people weighing at least 35 kilograms (77\u00a0lb).[2][3]References[edit]^ “Evotaz 300 mg\/150 mg film-coated tablets – Summary of Product Characteristics (SmPC)”. (emc). Retrieved 9 July 2021.^ a b c d e “Evotaz- atazanavir and cobicistat tablet”. DailyMed. Retrieved 25 May 2021.^ a b c d e “Evotaz EPAR”. European Medicines Agency (EMA). Retrieved 25 May 2021.^ Crutchley RD, Guduru RC, Cheng AM (2016). “Evaluating the role of atazanavir\/cobicistat and darunavir\/cobicistat fixed-dose combinations for the treatment of HIV-1 infection”. HIV\/AIDS: Research and Palliative Care. 8: 47\u201365. doi:10.2147\/HIV.S99063. PMC\u00a04790521. PMID\u00a027022304.^ “U.S. Food and Drug Administration Approves Bristol-Myers Squibb’s Evotaz (atazanavir and cobicistat) for the Treatment of HIV-1 Infection in Adults” (Press release). Bristol-Myers Squibb. Archived from the original on 2020-08-08. Retrieved 2018-06-28.^ “Evotaz (atazanavir and cobicistat) Tablet”. U.S. Food and Drug Administration (FDA). 15 April 2016. Retrieved 25 May 2021. “Summary Report” (PDF).External links[edit]li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:\" \"counter(listitem)\"a0 \"}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:\" (\"counter(listitem)\"a0 \"}]]>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}]]>Wikimedia ErrorOur servers are currently under maintenance or experiencing a technical problem.Please try again in a few\u00a0minutes.See the error message at the bottom of this page for more\u00a0information. "},{"@context":"http:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https:\/\/wiki.edu.vn\/en\/wiki19\/#breadcrumbitem","name":"Enzyklop\u00e4die"}},{"@type":"ListItem","position":2,"item":{"@id":"https:\/\/wiki.edu.vn\/en\/wiki19\/atazanavir-cobicistat-wikipedia\/#breadcrumbitem","name":"Atazanavir\/cobicistat – Wikipedia"}}]}]